Company Encyclopedia
View More
name
BNB Plus
BNBX.US
BNB Plus Corp. provides digital asset treasury services. The company offers real-time data tracking of treasury performance and market indicators. The company, through its subsidiaries, also develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in the Americas, Europe, Asia, and internationally.
770.89 B
BNBX.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
B
Life Sciences Tools and ServicesIndustry
Industry Ranking12/60
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE415.23%A
    • Profit Margin-352.27%E
    • Gross Margin1.69%E
  • Growth ScoreB
    • Revenue YoY55.60%A
    • Net Profit YoY676.55%A
    • Total Assets YoY-40.48%E
    • Net Assets YoY-42.88%E
  • Cash ScoreB
    • Cash Flow Margin9.20%C
    • OCF YoY55.60%A
  • Operating ScoreD
    • Turnover0.28D
  • Debt ScoreB
    • Gearing Ratio29.66%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Applied DNA Sciences Rebrands to BNB Plus Corp.

    Applied DNA Sciences has rebranded to BNB Plus Corp., effective November 13, 2025, with a new focus on BNB-based digital asset treasury strategies. The ticker has changed to BNBX, and Josh Kruger is appointed as Chairman of the Board. Despite strategic moves, the company faces financial challenges, with Spark's AI Analyst rating BNBX as Neutral due to declining revenues and poor technical indicators.

    Tip Ranks·
    US
    BNBX
    -0.32%
    Tip Ranks·
    US
    BNBX
    -0.32%

    Applied DNA Sciences Names Josh Kruger Chairman in Leadership Shift

    Applied DNA Sciences Inc. has rebranded as BNB Plus Corp. and appointed Josh Kruger as Chairman of the Board, replacing Judy Murrah, who will remain as a Director. This leadership shift marks a significant change for the company.

    Reuters·
    US
    BNBX
    -0.32%
    US
    APDN
    0.00%
    Reuters·
    US
    BNBX
    -0.32%
    US
    APDN
    0.00%

    Joshua Kruger Named Chairman of Applied DNA Sciences

    Applied DNA Sciences Inc. has appointed Joshua Kruger as its new Chairman and director, succeeding Sanford R. Simon. Judith Murrah has resigned as Chairperson but will remain a director. This announcement was made public via EDGAR on November 10, 2025.

    Reuters·
    US
    BNBX
    -0.32%
    US
    APDN
    0.00%
    Reuters·
    US
    BNBX
    -0.32%
    US
    APDN
    0.00%

    Applied DNA Sciences Signs Market Offering Agreement

    Applied DNA Sciences (BNBX) has signed an At The Market Offering Agreement with Lucid Capital Markets to sell shares valued up to $8,157,932. The company can sell shares at market prices but is not obligated to do so. Spark's AI Analyst rates BNBX as Neutral, citing financial challenges, declining revenues, and poor technical indicators. The company focuses on DNA-based technology solutions for supply chain security and anti-counterfeiting in various industries. Current market cap is $4.39M with an average trading volume of 1,341,252.

    Tip Ranks·
    US
    BNBX
    -0.32%
    Tip Ranks·
    US
    BNBX
    -0.32%

    Applied DNA Sciences Inc. Announces Date for Upcoming Special Meeting of Stockholders

    Applied DNA Sciences Inc. has announced a Special Meeting of Stockholders scheduled for December 12, 2025. The meeting will be held online and will address matters set forth by the Board of Directors, along with any additional matters that may arise for voting as recommended by the Board.

    Reuters·
    US
    BNBX
    -0.32%
    US
    APDN
    0.00%
    Reuters·
    US
    BNBX
    -0.32%
    US
    APDN
    0.00%
    © 2025 Longbridge｜Disclaimer